{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:07Z","timestamp":1786991467716,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Community Pharmacy Foundation","award":["#214"],"award-info":[{"award-number":["#214"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.japh.2020.06.007","type":"journal-article","created":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T09:13:24Z","timestamp":1595150004000},"page":"e332-e340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and feasibility of a community pharmacy\u2013driven 24-hour ambulatory blood pressure monitoring service"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-9521","authenticated-orcid":false,"given":"Dave L.","family":"Dixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Gatewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tana","family":"Kaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jadallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hawkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1009-291X","authenticated-orcid":false,"given":"Jewlyus","family":"Grigsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Holdford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.japh.2020.06.007_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11906-013-0340-9","article-title":"High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs","volume":"15","author":"Bromfield","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.japh.2020.06.007_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990\u20132015 [published correction appears in JAMA. 2017 Feb 14;317(6):648","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.japh.2020.06.007_bib3","first-page":"1","article-title":"Hypertension-related mortality in the United States, 2000-2013","volume":"193","author":"Kung","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"19","key":"10.1016\/j.japh.2020.06.007_bib4","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2017","journal-title":"J\u00a0Am Coll Cardiol. 2018"},{"issue":"6","key":"10.1016\/j.japh.2020.06.007_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjhyper.2006.12.013","article-title":"Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension","volume":"20","author":"Stergiou","year":"2007","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.japh.2020.06.007_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/HYPERTENSIONAHA.119.13542","article-title":"Superiority of out-of-office blood pressure for predicting hypertensive heart disease in non-Hispanic black adults","volume":"74","author":"Rader","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.japh.2020.06.007_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study","volume":"46","author":"Dolan","year":"2005","journal-title":"Hypertension"},{"issue":"24","key":"10.1016\/j.japh.2020.06.007_bib8","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa022273","article-title":"Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension","volume":"348","author":"Clement","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.japh.2020.06.007_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/M14-1539","article-title":"Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force","volume":"162","author":"Piper","year":"2015","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.japh.2020.06.007_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/M19-0223","article-title":"Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis","volume":"170","author":"Cohen","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.japh.2020.06.007_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/HYPERTENSIONAHA.116.07553","article-title":"Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: the Jackson heart study","volume":"68","author":"Booth","year":"2016","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.japh.2020.06.007_bib12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","article-title":"European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring","volume":"32","author":"Parati","year":"2014","journal-title":"J\u00a0Hypertens"},{"issue":"9","key":"10.1016\/j.japh.2020.06.007_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jash.2017.06.012","article-title":"Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States","volume":"11","author":"Kronish","year":"2017","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"1","key":"10.1016\/j.japh.2020.06.007_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11906-018-0805-y","article-title":"Implementing ABPM into clinical practice","volume":"20","author":"Hinderliter","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"10.1016\/j.japh.2020.06.007_bib15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/jch.13719","article-title":"Medicare reimbursement policy for ambulatory blood pressure monitoring: a qualitative analysis of public comments to the Centers for Medicare and Medicaid Services","volume":"21","author":"Dixon","year":"2019","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"9","key":"10.1016\/j.japh.2020.06.007_bib16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring [published correction appears in J Hypertens. 2013 Dec;31(12):2467]","volume":"31","author":"O\u2019Brien","year":"2013","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.japh.2020.06.007_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MBP.0000000000000034","article-title":"Making ambulatory blood pressure monitoring accessible in pharmacies","volume":"19","author":"James","year":"2014","journal-title":"Blood Press Monit"},{"issue":"4","key":"10.1016\/j.japh.2020.06.007_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2146\/ajhp160113","article-title":"Pharmacist-managed ambulatory blood pressure monitoring service","volume":"74","author":"Khazan","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.japh.2020.06.007_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2296-4-15","article-title":"Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey","volume":"4","author":"Ernst","year":"2003","journal-title":"BMC Fam Pract"},{"issue":"5","key":"10.1016\/j.japh.2020.06.007_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.amepre.2009.02.002","article-title":"How we design feasibility studies","volume":"36","author":"Bowen","year":"2009","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.japh.2020.06.007_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00126097-200408000-00007","article-title":"Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices","volume":"9","author":"Jones","year":"2004","journal-title":"Blood Press Monit"},{"issue":"2","key":"10.1016\/j.japh.2020.06.007_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MBP.0b013e3280acab1b","article-title":"Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol","volume":"12","author":"Goodwin","year":"2007","journal-title":"Blood Press Monit"},{"issue":"11","key":"10.1016\/j.japh.2020.06.007_bib23","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00004872-200211000-00017","article-title":"Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the ohasama study","volume":"20","author":"Ohkubo","year":"2002","journal-title":"J\u00a0Hypertens"},{"issue":"10","key":"10.1016\/j.japh.2020.06.007_bib24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jch.12589","article-title":"Nocturnal hypertension correlates better\u00a0with target organ damage in patients with chronic kidney disease than a nondipping pattern","volume":"17","author":"Wang","year":"2015","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"9","key":"10.1016\/j.japh.2020.06.007_bib25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/jamacardio.2019.2845","article-title":"Association of daytime and nighttime blood pressure with cardiovascular disease events among African American individuals [published correction appears in JAMA Cardiol. 2019 Sep 1;4(9):953]","volume":"4","author":"Yano","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.japh.2020.06.007_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MBP.0000000000000166","article-title":"The use of ambulatory blood pressure monitoring to confirm a diagnosis of high blood pressure by primary-care physicians in Oregon","volume":"21","author":"Carter","year":"2016","journal-title":"Blood Press Monit"},{"issue":"1","key":"10.1016\/j.japh.2020.06.007_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.japh.2018.11.007","article-title":"Pharmacist-provided services: barriers to demonstrating value","volume":"59","author":"Nguyen","year":"2019","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"8","key":"10.1016\/j.japh.2020.06.007_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/phar.1414","article-title":"Economic evaluations of clinical pharmacy services: 2006\u20132010","volume":"34","author":"Touchette","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.japh.2020.06.007_bib29","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jash.2014.09.020","article-title":"Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries","volume":"8","author":"Kent","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"3","key":"10.1016\/j.japh.2020.06.007_bib31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.18549\/PharmPract.2018.03.1351","article-title":"Resource-based theory of competitive advantage \u2013 a framework for pharmacy practice innovation research","volume":"16","author":"Holdford","year":"2018","journal-title":"Pharm Pract (Granada)"},{"issue":"1","key":"10.1016\/j.japh.2020.06.007_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/HYPERTENSIONAHA.118.11715","article-title":"Comparative cost-effectiveness of clinic, home, or ambulatory blood pressure measurement for hypertension diagnosis in US adults","volume":"73","author":"Beyhaghi","year":"2019","journal-title":"Hypertension"},{"issue":"9798","key":"10.1016\/j.japh.2020.06.007_bib33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(11)61184-7","article-title":"Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study [published correction appears in Lancet. 2011 Oct 1;378(9798):1218]","volume":"378","author":"Lovibond","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.japh.2020.06.007_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.HYP.0000197195.84725.66","article-title":"Cost-effectiveness of ambulatory blood pressure: a reanalysis","volume":"47","author":"Krakoff","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.japh.2020.06.007_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pharmacy7030106","article-title":"Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States","volume":"7","author":"Goode","year":"2019","journal-title":"Pharmacy (Basel)"},{"issue":"21","key":"10.1016\/j.japh.2020.06.007_bib36","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1001\/archinte.168.21.2355","article-title":"A\u00a0randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN)","volume":"168","author":"McLean","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.japh.2020.06.007_bib37","first-page":"453","article-title":"Usefulness of blood pressure measurement by community pharmacists in the management of hypertension","volume":"18","author":"Sabater-Hern\u00e1ndez","year":"2012","journal-title":"J\u00a0Manag Care Pharm"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:48:54Z","timestamp":1761544134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120302739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1544319120302739"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.007","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and feasibility of a community pharmacy\u2013driven 24-hour ambulatory blood pressure monitoring service","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}